Company / Shareholders' Equity
Solventum Shareholders' Equity History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.0B
FY2025
5-year range
$3.0B / $11.7B
FY2022-FY2025
Trend
+70.6%
vs FY2024
Sector context
#31 of 161
Health Care
What the data says
Solventum's shareholders' equity of $5.0B is higher than 81% of companies in the Health Care sector (FY2025). Shareholders' Equity returned to growth in FY2025 after 2 years of decline, reaching $5.0B.
Based on SEC 10-K filings.
$5.0B in FY2025 with a 3-year CAGR of -24.5%. Top quartile in the Health Care sector.
Declined from $11.7B to $5.0B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -24.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 19% of 161This company $5.0B Sector average $5.1B
▼
In line with sector average
Key checks
Key Insights
- 3-year CAGR of -24.5%, indicating a declining trend.
- In FY2025, shareholders' equity increased 70.6% year-over-year.
- Ranks #31 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0B | +70.6% |
| FY2024 | $3.0B | -74.6% |
| FY2023 | $11.7B | -0.6% |
| FY2022 | $11.7B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026